Error: Could not add to watchlist. X
+ Watchlist

Candriam Equities L Biotechnology

CAELBRC:LX
152.98
CHF
2.60
1.73%
As of 11/16/2017
Fund Type
SICAV
52Wk Range
125.72 - 168.28
YTD Return
21.68%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
150.38
52Wk Range
125.72 - 168.28
YTD Return
21.68%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 11/16/2017)
152.98
Total Assets (m USD) (on 11/16/2017)
820.320
Inception Date
08/17/2015
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
RUDI VAN DEN EYNDE
Front Load Fee
3.50%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
0.75%
Expense Ratio
-

Top Fund Holdings

Name Position Value % of Fund
225.25 k 70.53 m 7.64
434.70 k 63.39 m 6.87
657.00 k 53.23 m 5.77
107.80 k 48.20 m 5.22
235.20 k 43.85 m 4.75
269.00 k 40.90 m 4.43
330.00 k 38.52 m 4.17
246.50 k 31.82 m 3.45
209.50 k 29.39 m 3.18
366.00 k 22.43 m 2.43
Profile
Candriam Equities L - Biotechnology is a SICAV incorporated under the laws of Luxembourg. The Fund's objective is capital appreciation. The Fund invests in global biotechnology stocks. Because the sector is currently experiencing the highest growth in the U.S., at least two-thirds of the Fund's assets will be invested in U.S. biotechnology stocks.
Address
Candriam Luxembourg
SERENITY - Bloc B
19-21 route d'Arlon
L-8009 STRASSEN - Luxembourg
Phone
352-2797-1